Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 2 , Pages 210-216 , April 2008

Perioperative Statin Therapy and Renal Outcomes After Major Vascular Surgery: A Propensity-Based Analysis

  • Daryl J. Kor, MD

      Affiliations

    • Department of Anesthesiology, Division of Critical Care, Mayo Clinic College of Medicine, Rochester, MN
    • Corresponding Author InformationAddress reprint requests to Daryl J. Kor, MD, Department of Anesthesiology, Division of Critical Care, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905.
    • ,
  • Michael J. Brown, MD

      Affiliations

    • Department of Anesthesiology, Division of Critical Care, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Remzi Iscimen, MD

      Affiliations

    • Department of Anesthesiology, Division of Critical Care, Mayo Clinic College of Medicine, Rochester, MN
    • Department of Anesthesiology and Reanimation, Uludag University School of Medicine, Bursa, Turkey.
    • ,
  • Daniel R. Brown, MD, PhD

      Affiliations

    • Department of Anesthesiology, Division of Critical Care, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Francis X. Whalen, MD

      Affiliations

    • Department of Anesthesiology, Division of Critical Care, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Tuhin K. Roy, MD, PhD

      Affiliations

    • Department of Anesthesiology, Division of Critical Care, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Mark T. Keegan, MD

      Affiliations

    • Department of Anesthesiology, Division of Critical Care, Mayo Clinic College of Medicine, Rochester, MN

References 

  1. Martin GH, O’Hara PJ, Hertzer NR, et al. Surgical repair of aneurysms involving the suprarenal, visceral, and lower thoracic aortic segments: Early results and late outcome. J Vasc Surg. 2000;31:851–862
  2. Svensson LG, Crawford ES, Hess KR, et al. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg. 1993;17:357–368discussion 68-70
  3. Morgera S, Kraft AK, Siebert G, et al. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis. 2002;40:275–279
  4. Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med. 2004;32:1669–1677
  5. O’Donnell D, Clarke G, Hurst P. Acute renal failure following surgery for abdominal aortic aneurysm. Aust N Z J Surg. 1989;59:405–408
  6. Braams R, Vossen V, Lisman BA, et al. Outcome in patients requiring renal replacement therapy after surgery for ruptured and non-ruptured aneurysm of the abdominal aorta. Eur J Vasc Endovasc Surg. 1999;18:323–327
  7. Gamulin Z, Forster A, Morel D, et al. Effects of infrarenal aortic cross-clamping on renal hemodynamics in humans. Anesthesiology. 1984;61:394–399
  8. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial (Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group). Lancet. 2000;356:2139–2143
  9. Holmes CL, Walley KR. Bad medicine: Low-dose dopamine in the ICU. Chest. 2003;123:1266–1275
  10. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97–104
  11. Lombardi R, Ferreiro A, Servetto C. Renal function after cardiac surgery: Adverse effect of furosemide. Ren Fail. 2003;25:775–786
  12. Carcoana OV, Mathew JP, Davis E, et al. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial. Anesth Analg. 2003;97:1222–1229
  13. Gueler F, Rong S, Park JK, et al. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol. 2002;13:2288–2298
  14. Yokota N, O’Donnell M, Daniels F, et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol. 2003;23:13–17
  15. Epstein M, Campese VM. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function. Am J Kidney Dis. 2005;45:2–14
  16. Naidu BV, Woolley SM, Farivar AS, et al. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg. 2003;126:482–489
  17. Pirat A, Zeyneloglu P, Aldemir D, et al. Pretreatment with simvastatin reduces lung injury related to intestinal ischemia-reperfusion in rats. Anesth Analg. 2006;102:225–232
  18. Tonelli M, Moye L, Sacks FM, et al. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol. 2003;14:1605–1613
  19. Vidt DG, Cressman MD, Harris S, et al. Rosuvastatin-induced arrest in progression of renal disease. Cardiology. 2004;102:52–60
  20. Yasuda H, Yuen PS, Hu X, et al. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int. 2006;69:1535–1542
  21. Schouten O, Kok NF, Boersma E, et al. Effects of statins on renal function after aortic cross-clamping during major vascular surgery. Am J Cardiol. 2006;97:1383–1385
  22. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure—Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–R212
  23. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848–1851
  24. Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004;291:2092–2099
  25. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial. J Vasc Surg. 2004;39:967–975discussion 75-76
  26. O’Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: The Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol. 2005;45:336–342
  27. Hindler K, Shaw AD, Samuels J, et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology. 2006;105:1260–1272
  28. Pruefer D, Makowski J, Schnell M, et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation. 2002;106:2104–2110
  29. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998;273:24266–24271
  30. Yao HW, Mao LG, Zhu JP. Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clin Exp Pharmacol Physiol. 2006;33:793–797
  31. Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003;53:743–751
  32. Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke. 2005;36:1627–1632
  33. Le Manach Y, Godet G, Coriat P, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg. 2007;104:1326–1333
  34. Schouten O, Hoeks SE, Welten GM, et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol. 2007;100:316–320

PII: S1053-0770(07)00403-X

doi: 10.1053/j.jvca.2007.12.019

Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 2 , Pages 210-216 , April 2008

Article Tools